JAK/STAT signaling is involved in the maintenance of CSC phenotype in various solid tumors, including breast cancer, esophageal cancer, glioblastoma, and colorectal cancer [191, 193, 194]. This evidence concerns the gene SOAT1 and colorectal cancer.